asco.org10d
Talazoparib and Enzalutamide Combination Improves Survival in Some Patients With Prostate Cancer
“The TALAPRO-2 study showed a significant improvement in overall survival in men with mCRPC treated with the combination of talazoparib and enzalutamide whether they had HRR gene alterations. In this ...
asco.org11d
FDA Approves Brentuximab Vedotin with Lenalidomide and Rituximab for Relapsed or Refractory Large B-Cell Lymphoma
The following is a message from the Director of the FDA Oncology Center of Excellence, Dr. Richard Pazdur: On February 11, 2025, the Food and Drug Administration approved brentuximab vedotin (Adcetris ...
asco.org5d
Advocacy Agenda & Initiatives
The Association for Clinical Oncology (ASCO) works to ensure that all people with cancer have access to high-quality, affordable cancer care, no matter who they are or where they live. ASCO advocates ...
asco.org10d
Federally Funded Cancer Research
Over the last 50 years, research funded by the National Institutes of Health (NIH) and National Cancer Institute (NCI) has played a role in every major advancement related to cancer prevention, ...
asco.org3d
Impact of Medicaid expansion on diagnosis and management of patients with testicular cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3d
Preliminary analysis of PD-1 inhibitors combined with chemotherapy as neoadjuvant therapy for local advanced non-small cell lung cancer (NSCLC).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3d
Update on lower-dose dasatinib 50 mg daily as frontline therapy in newly diagnosed chronic phase chronic myeloid leukemia (CML-CP).
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3d
Patient interest in exploring nonsurgical treatment approaches for early-stage breast cancer: A qualitative study.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3d
Tumor suppressor genes (TSG), treatment, and survival in de novo metastatic hormone-sensitive prostate cancer.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org6d
ASCO Certified: Patient-Centered Cancer Care Standards
To learn more about the Oncology Medical Home standards and ASCO Certified recognition from ASCO, please click the button below and submit your questions. ASCO Certified has launched a new application ...
asco.org3d
Surgical management of testicular cancer patients with complex postchemotherapy residual masses: Aachen University experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...
asco.org3d
Long-term outcomes of radiotherapy for stage II testicular seminoma: The Mayo Clinic experience.
This material on this page is ©2025 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please ...